Delivery Order SPE2DB20D2104-SPE2DB25FMHMD

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,559.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the procurement of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML, a pharmaceutical product, to support military...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,722.12 fixed-price delivery order is for the procurement of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a diabetes medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,110.14 Firm Fixed Price Delivery Order contract is for the supply of the medication VICTOZA 3-PAK 18 MG/3 ML PEN 3ML. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,730.56 firm fixed-price delivery order contract is for the supply of VICTOZA 3-pak 18 mg/3 ml pens. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing a range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,080.29 delivery order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a specialized medication used for diabetes management. The contract has a firm fixed price pricing type and a period of performance through November 25, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,343.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML, a specialty medication, with an ultimate completion date of June 11, 2024. The contract is a firm fixed-price arrangement, and there is no set-aside designation mentioned. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,767.02 firm-fixed-price delivery order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a prescription medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award for $1,323.57 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a delivery order type and firm fixed price pricing, is for the supply of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML. The award has an ultimate completion date of August 21, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,966.32 delivery order contract is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication used to treat diabetes. The contract has an ultimate completion date of August 31, 2022 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,327.98 fixed-price delivery order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a diabetes medication. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMHMD
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,195.82 Firm Fixed Price Delivery Order is for the supply of "VICTOZA 2-PAK 18 MG/3 ML PEN 3ML" pharmaceutical products. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to military healthcare programs globally. This contract does not have a set-aside designation, indicating open competition. The contract supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined contracting mechanism.

Generated 5/7/25, 9:50 AM